![]() ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2010 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Philadelphia, US HQ | Locations Cambridge, US HQ |
Employees | Employees 36817% increase | Employees 2 |
Funding | ||
Total funding raised | Total funding raised $ 122.8m | Total funding raised $ 72.8m |

ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View company